Novi-Beograd, Serbia Clinical Trials

A listing of Novi-Beograd, Serbia clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on …

semaglutide
chronic disease
stroke
Novo Nordisk Investigational Site
 (3.7 away) Contact site
  • 1276 views
  • 01 Aug, 2021
  • +557 other locations
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

The purpose of this study is to evaluate whether the addition of selexipag to standard of care treatment delays disease progression in children with Pulmonary Arterial Hypertension (PAH) in comparison to placebo.

heart disease
endothelin
endothelin receptor antagonist
right heart catheterization
primary pulmonary hypertension
Univerzitetska De ja Klinika
 (3.7 away) Contact site
  • 169 views
  • 18 Jul, 2021
  • +149 other locations
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Patients With Severe Hemophilia A or B

Treatment with PF-06741086 is anticipated to demonstrate a clinically relevant advantage and/or a major contribution to patient care in comparison to current methods of treatment for hemophilia A or B because it works differently than factor replacement products and will work in the presence of inhibitors. The potential for once …

hemophilia
coagulation factor
replacement therapy
Factor VIII
severe haemophilia a
Clinical Center of Serbia
 (3.7 away) Contact site
  • 58 views
  • 14 Jul, 2021
  • +74 other locations
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).

lupus
Clinical Center of Serbia
 (3.7 away) Contact site
  • 503 views
  • 31 Jul, 2021
  • +556 other locations
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

The purpose of the MycarinGstudy is to demonstrate the clinical efficacy and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG).

generalized myasthenia gravis
plasma exchange
igiv
immune globulin
rozanolixizumab
Mg0003 40468
 (4.0 away) Contact site
  • 76 views
  • 01 Aug, 2021
  • +130 other locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

crohn's disease
ustekinumab
Clinical Center Zemun
 (3.0 away) Contact site
  • 646 views
  • 25 Jul, 2021
  • +991 other locations
Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

This study will assess the safety and efficacy of cefepime/VNRX-5133 compared with meropenem in both eradication of bacteria and in symptomatic response in patients with cUTIs.

pyelonephritis
cefepime
acute pyelonephritis
meropenem
Site 189001
 (3.7 away) Contact site
  • 145 views
  • 28 Jun, 2021
  • +102 other locations
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blinded treatment (either etrasimod 2 mg per day or placebo) during participation in one of two Phase 3 double-blinded, placebo-controlled …

Clinical Center " Dr Dragisa Misovic Dedinje"
 (3.7 away) Contact site
  • 133 views
  • 02 Aug, 2021
  • +390 other locations
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

The purpose of this study is to assess the efficacy of seltorexant compared with quetiapine extended-release (XR) as adjunctive therapy to an antidepressant drug in treatment response in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective …

body mass index
levomilnacipran
depressive symptoms
paroxetine
psychiatric disorder
Bel Medic General Hospital
 (3.7 away) Contact site
  • 124 views
  • 02 Aug, 2021
  • +179 other locations
Linaclotide Safety and Efficacy in Pediatric Participants 6 to 17 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)

The objective of LIN-MD-64 is to evaluate the safety and efficacy of 12 weeks of linaclotide therapy (72 g daily) in comparison with placebo in pediatric participants, 6 to 17 years of age, who fulfill modified Rome III Criteria for Child/Adolescent Functional Constipation (FC). The objective of LIN-MD-64 is to …

posturing
incontinence
laxative
University Children's Hospital - Tirsova
 (3.7 away) Contact site
  • 136 views
  • 01 Aug, 2021
  • +298 other locations